Sonoma Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

3. Summary of Significant Accounting Policies (Details - Potentially Dilutive Securities)

3. Summary of Significant Accounting Policies (Details - Potentially Dilutive Securities)	9 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Total securities excluded from computation of basic net loss per share	4,837,000	2,587,000
Stock Options [Member]
Total securities excluded from computation of basic net loss per share	2,805,000	1,253,000
Warrants [Member]
Total securities excluded from computation of basic net loss per share	2,032,000	1,334,000

- Definition

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

+ References + Details